Katy Trinkley
Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Decision Support Systems, Clinical | 7 | 2023 | 180 | 4.160 |
Why?
| Pharmacists | 7 | 2019 | 245 | 3.020 |
Why?
| Primary Health Care | 9 | 2020 | 1625 | 2.100 |
Why?
| Pharmacy Service, Hospital | 3 | 2019 | 88 | 1.450 |
Why?
| Medical Order Entry Systems | 2 | 2021 | 43 | 1.440 |
Why?
| Irritable Bowel Syndrome | 3 | 2015 | 30 | 1.400 |
Why?
| Lisinopril | 2 | 2020 | 14 | 1.390 |
Why?
| Long QT Syndrome | 3 | 2022 | 59 | 1.380 |
Why?
| Heart Failure | 6 | 2023 | 2114 | 1.320 |
Why?
| Practice Patterns, Physicians' | 5 | 2020 | 1267 | 1.250 |
Why?
| Physicians | 3 | 2023 | 824 | 1.100 |
Why?
| Hypertension | 4 | 2020 | 1245 | 1.090 |
Why?
| Electronic Health Records | 7 | 2022 | 842 | 0.960 |
Why?
| Constipation | 3 | 2015 | 75 | 0.960 |
Why?
| Interprofessional Relations | 2 | 2015 | 271 | 0.850 |
Why?
| Professional Role | 3 | 2019 | 162 | 0.840 |
Why?
| Losartan | 1 | 2020 | 12 | 0.790 |
Why?
| Angioedema | 1 | 2020 | 17 | 0.770 |
Why?
| Pharmaceutical Services | 2 | 2019 | 80 | 0.740 |
Why?
| Antihypertensive Agents | 2 | 2020 | 465 | 0.700 |
Why?
| Costs and Cost Analysis | 1 | 2020 | 211 | 0.700 |
Why?
| Antipsychotic Agents | 2 | 2018 | 197 | 0.690 |
Why?
| Pharmaceutical Preparations | 1 | 2021 | 168 | 0.670 |
Why?
| Dementia | 2 | 2018 | 211 | 0.650 |
Why?
| Pharmacies | 2 | 2019 | 31 | 0.610 |
Why?
| Health Personnel | 2 | 2020 | 603 | 0.610 |
Why?
| Community Pharmacy Services | 1 | 2017 | 47 | 0.600 |
Why?
| Chronic Pain | 2 | 2019 | 214 | 0.600 |
Why?
| Depression | 4 | 2019 | 1190 | 0.590 |
Why?
| Referral and Consultation | 2 | 2019 | 669 | 0.580 |
Why?
| Program Development | 1 | 2018 | 372 | 0.550 |
Why?
| Nursing Informatics | 1 | 2016 | 26 | 0.550 |
Why?
| Humans | 38 | 2023 | 122796 | 0.540 |
Why?
| Analgesics, Opioid | 2 | 2015 | 785 | 0.540 |
Why?
| Benzodiazepines | 1 | 2016 | 125 | 0.540 |
Why?
| Patient Transfer | 1 | 2017 | 156 | 0.530 |
Why?
| Medication Adherence | 1 | 2020 | 575 | 0.520 |
Why?
| Students, Pharmacy | 1 | 2016 | 102 | 0.520 |
Why?
| Cyclohexanols | 1 | 2014 | 10 | 0.510 |
Why?
| Patient Care Team | 2 | 2016 | 520 | 0.510 |
Why?
| Education, Pharmacy | 1 | 2016 | 131 | 0.500 |
Why?
| Stroke Volume | 3 | 2023 | 553 | 0.500 |
Why?
| Pain Management | 1 | 2017 | 306 | 0.490 |
Why?
| Nurse Practitioners | 1 | 2016 | 112 | 0.490 |
Why?
| Fibromyalgia | 1 | 2014 | 58 | 0.490 |
Why?
| Blood Pressure | 2 | 2020 | 1713 | 0.480 |
Why?
| Torsades de Pointes | 1 | 2013 | 22 | 0.470 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 1 | 2016 | 240 | 0.470 |
Why?
| Registries | 2 | 2020 | 2020 | 0.460 |
Why?
| Phentermine | 1 | 2013 | 10 | 0.460 |
Why?
| Computer-Assisted Instruction | 1 | 2014 | 67 | 0.460 |
Why?
| Patient Safety | 1 | 2016 | 302 | 0.450 |
Why?
| Telemedicine | 3 | 2020 | 691 | 0.450 |
Why?
| Anti-Obesity Agents | 1 | 2013 | 49 | 0.440 |
Why?
| Medical Informatics | 1 | 2014 | 108 | 0.440 |
Why?
| Cooperative Behavior | 1 | 2015 | 410 | 0.430 |
Why?
| Sleep Wake Disorders | 1 | 2016 | 289 | 0.430 |
Why?
| Retrospective Studies | 10 | 2023 | 13433 | 0.420 |
Why?
| User-Computer Interface | 1 | 2013 | 164 | 0.420 |
Why?
| Metformin | 1 | 2015 | 303 | 0.410 |
Why?
| Electrocardiography | 2 | 2022 | 620 | 0.410 |
Why?
| Fructose | 1 | 2013 | 204 | 0.400 |
Why?
| Patient Discharge | 1 | 2017 | 842 | 0.400 |
Why?
| Anxiety | 1 | 2016 | 888 | 0.360 |
Why?
| Aged | 11 | 2020 | 20495 | 0.360 |
Why?
| Focus Groups | 2 | 2023 | 391 | 0.350 |
Why?
| Internet | 1 | 2014 | 686 | 0.330 |
Why?
| Public Health | 1 | 2013 | 480 | 0.320 |
Why?
| Hypoglycemic Agents | 1 | 2015 | 1055 | 0.310 |
Why?
| Middle Aged | 11 | 2020 | 28563 | 0.310 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 1213 | 0.310 |
Why?
| Male | 15 | 2020 | 59639 | 0.280 |
Why?
| Behavior | 2 | 2019 | 99 | 0.270 |
Why?
| Female | 15 | 2020 | 63629 | 0.270 |
Why?
| Patient Participation | 2 | 2020 | 371 | 0.250 |
Why?
| Pain | 1 | 2010 | 746 | 0.250 |
Why?
| Treatment Outcome | 5 | 2020 | 9692 | 0.250 |
Why?
| Aged, 80 and over | 4 | 2020 | 6845 | 0.240 |
Why?
| Reproducibility of Results | 2 | 2022 | 2977 | 0.240 |
Why?
| Disease Management | 2 | 2020 | 591 | 0.230 |
Why?
| Prescriptions | 1 | 2023 | 67 | 0.230 |
Why?
| Program Evaluation | 2 | 2019 | 880 | 0.230 |
Why?
| Antidepressive Agents | 2 | 2017 | 194 | 0.220 |
Why?
| Dose-Response Relationship, Drug | 2 | 2020 | 1981 | 0.210 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2015 | 2221 | 0.210 |
Why?
| Behavioral Symptoms | 2 | 2018 | 44 | 0.200 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2023 | 302 | 0.190 |
Why?
| Evaluation Studies as Topic | 1 | 2020 | 190 | 0.180 |
Why?
| Prospective Studies | 3 | 2016 | 6704 | 0.180 |
Why?
| Surveys and Questionnaires | 3 | 2016 | 4882 | 0.180 |
Why?
| Cross-Sectional Studies | 3 | 2017 | 4734 | 0.180 |
Why?
| Obesity | 1 | 2013 | 2786 | 0.180 |
Why?
| Grounded Theory | 1 | 2019 | 31 | 0.170 |
Why?
| Ambulatory Care | 2 | 2015 | 497 | 0.170 |
Why?
| Biological Specimen Banks | 1 | 2020 | 107 | 0.170 |
Why?
| Pharmacogenetics | 1 | 2020 | 151 | 0.170 |
Why?
| Sex Factors | 2 | 2015 | 1860 | 0.170 |
Why?
| Drug Administration Schedule | 1 | 2020 | 757 | 0.170 |
Why?
| Curriculum | 2 | 2016 | 925 | 0.160 |
Why?
| United States | 4 | 2018 | 13272 | 0.160 |
Why?
| Medication Therapy Management | 1 | 2019 | 73 | 0.160 |
Why?
| Residential Facilities | 1 | 2017 | 6 | 0.160 |
Why?
| Evidence-Based Medicine | 2 | 2014 | 731 | 0.160 |
Why?
| Models, Organizational | 1 | 2018 | 144 | 0.150 |
Why?
| Independent Living | 1 | 2018 | 90 | 0.150 |
Why?
| Academic Medical Centers | 1 | 2020 | 427 | 0.150 |
Why?
| Medication Errors | 1 | 2017 | 98 | 0.150 |
Why?
| Chronic Disease | 2 | 2020 | 1645 | 0.140 |
Why?
| Telenursing | 1 | 2016 | 10 | 0.140 |
Why?
| Intersectoral Collaboration | 1 | 2016 | 61 | 0.140 |
Why?
| Precision Medicine | 1 | 2020 | 371 | 0.140 |
Why?
| Adult | 6 | 2020 | 32385 | 0.140 |
Why?
| Laxatives | 1 | 2015 | 18 | 0.140 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 228 | 0.140 |
Why?
| Health Care Surveys | 1 | 2017 | 564 | 0.130 |
Why?
| Office Visits | 1 | 2015 | 94 | 0.130 |
Why?
| Quality Improvement | 2 | 2020 | 1004 | 0.130 |
Why?
| Venlafaxine Hydrochloride | 1 | 2014 | 12 | 0.130 |
Why?
| Delivery of Health Care | 1 | 2022 | 915 | 0.130 |
Why?
| Perception | 1 | 2017 | 324 | 0.130 |
Why?
| Young Adult | 3 | 2016 | 11094 | 0.120 |
Why?
| Drugs, Investigational | 1 | 2014 | 31 | 0.120 |
Why?
| Interviews as Topic | 1 | 2016 | 601 | 0.120 |
Why?
| Systems Integration | 1 | 2014 | 42 | 0.120 |
Why?
| PubMed | 1 | 2013 | 12 | 0.120 |
Why?
| Models, Educational | 1 | 2014 | 100 | 0.110 |
Why?
| Drug Combinations | 1 | 2013 | 292 | 0.110 |
Why?
| Communication | 1 | 2017 | 776 | 0.100 |
Why?
| Follow-Up Studies | 1 | 2020 | 4768 | 0.100 |
Why?
| Adolescent | 3 | 2016 | 18948 | 0.100 |
Why?
| Teaching | 1 | 2014 | 241 | 0.100 |
Why?
| Parasympatholytics | 1 | 2010 | 14 | 0.100 |
Why?
| Antidiarrheals | 1 | 2010 | 14 | 0.100 |
Why?
| Controlled Clinical Trials as Topic | 1 | 2010 | 27 | 0.100 |
Why?
| Life Style | 1 | 2013 | 436 | 0.100 |
Why?
| Dietary Fiber | 1 | 2010 | 46 | 0.090 |
Why?
| Attitude of Health Personnel | 1 | 2017 | 1012 | 0.090 |
Why?
| Diarrhea | 1 | 2010 | 181 | 0.090 |
Why?
| Abdominal Pain | 1 | 2010 | 141 | 0.090 |
Why?
| Clinical Competence | 1 | 2016 | 973 | 0.080 |
Why?
| Cohort Studies | 1 | 2019 | 5294 | 0.080 |
Why?
| Colorado | 2 | 2020 | 4325 | 0.080 |
Why?
| Risk Factors | 2 | 2013 | 9381 | 0.080 |
Why?
| Age Factors | 1 | 2015 | 3114 | 0.080 |
Why?
| Dietary Supplements | 1 | 2010 | 473 | 0.070 |
Why?
| Drug Overdose | 1 | 2010 | 273 | 0.070 |
Why?
| Cluster Analysis | 1 | 2022 | 493 | 0.050 |
Why?
| Health Services Misuse | 1 | 2020 | 36 | 0.050 |
Why?
| Cytochrome P-450 CYP2C19 | 1 | 2020 | 21 | 0.050 |
Why?
| Quality of Life | 1 | 2010 | 2457 | 0.040 |
Why?
| Machine Learning | 1 | 2022 | 345 | 0.040 |
Why?
| Long-Term Care | 1 | 2017 | 73 | 0.040 |
Why?
| Child | 1 | 2016 | 19561 | 0.040 |
Why?
| Ventricular Dysfunction, Left | 1 | 2020 | 401 | 0.040 |
Why?
| Physician-Patient Relations | 1 | 2020 | 509 | 0.030 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2020 | 1260 | 0.030 |
Why?
|
|
Trinkley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|